Tiziana Life Sciences Plc - Company Profile
Powered by 
All the data and insights you need on Tiziana Life Sciences Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Tiziana Life Sciences Plc Strategy Report
- Understand Tiziana Life Sciences Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Tiziana Life Sciences Plc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| IL310582A | Application | Combination therapy for the treatment of pan-kras mutated cancers | A61K2300/00; A61K31/404; A61K31/44; A61K31/4745; A61K31/513; A61K31/519; A61K31/555; A61K31/7068; A61K33/243; A61K45/06; A61K9/0019; A61P35/00 | April 01, 2024 |
| EP4323404A1 | Application | Subkutane verabreichung von antikörpern zur behandlung von krankheiten | A61K2039/505; A61K2039/54; A61P1/16; A61P29/00; A61P3/10; C07K16/248; C07K16/2809; C07K2317/24; C07K2317/56; C07K2317/565; C07K2317/76; C07K2317/92 | February 21, 2024 |
| AU2022326184A1 | Application | Combination therapy for the treatment of pan-kras mutated cancers | A61K31/404; A61K31/44; A61K31/4745; A61K31/513; A61K31/519; A61K31/555; A61K31/7068; A61K33/243; A61K45/06; A61K9/0019; A61P35/00 | February 15, 2024 |
| US20230365689A1 | Application | Nasal formulations of foralumab | A61K47/02; A61K47/12; A61K47/24; A61K47/26; A61K9/0043; A61P25/28; C07K16/2809 | November 16, 2023 |
| WO2023218100A1 | Application | Nasal formulations of foralumab | A61K47/02; A61K47/12; A61K47/24; A61K47/26; A61K9/0043; A61P25/28; C07K16/2809 | November 16, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer